CAL
WST icon

Capital Advisors Ltd’s West Pharmaceutical WST Stock Holding History

Capital Advisors Ltd’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Buy
43
+2
+5% +$611 ﹤0.01% 763
2026
Q1 		$10K Sell
41
-1
-2% -$249 ﹤0.01% 839
2025
Q4 		$12K Buy
42
+2
+5% +$547 ﹤0.01% 776
2025
Q3 		$10K Hold
40
– – ﹤0.01% 815
2025
Q2 		$9K Buy
40
+39
+3,900% +$8.34K ﹤0.01% 830
2025
Q1 		$0 Sell
1
-14
-93% -$3.86K ﹤0.01% 1610
2024
Q4 		$5K Buy
15
+1
+7% +$315 ﹤0.01% 956
2024
Q3 		$4K Buy
14
+3
+27% +$919 ﹤0.01% 976
2024
Q2 		$4K Hold
11
– – ﹤0.01% 967
2024
Q1 		$4K Hold
11
– – ﹤0.01% 947
2023
Q4 		$4K Hold
11
– – ﹤0.01% 920
2023
Q3 		$4K Hold
11
– – ﹤0.01% 904
2023
Q2 		$4K Hold
11
– – ﹤0.01% 914
2023
Q1 		$4K Hold
11
– – ﹤0.01% 777
2022
Q4 		$3K Buy
11
+7
+175% +$1.66K ﹤0.01% 808
2022
Q3 		$1K Buy
+4
New +$1.22K ﹤0.01% 1157
2022
Q1 		– Sell
-1
Closed – – 1239
2021
Q4 		$0 Buy
+1
New +$430 ﹤0.01% 960

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
BZWA
Blue Zone Wealth Advisors Los Angeles, California $573M AUM 22.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Capital Advisors Ltd's WST Position: Q2 2026 in Review

Capital Advisors Ltd increased its West Pharmaceutical (WST) stake by 4.9% in Q2 2026, buying an estimated $611 and bringing the position to 43 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #763.

Capital Advisors Ltd first reported a position in WST in Q4 2021 and has held it in 17 quarters since. 120 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Capital Advisors Ltd held 43 shares of West Pharmaceutical worth $15K as of Q2 2026.
  • Capital Advisors Ltd bought 2 West Pharmaceutical shares in Q2 2026, an estimated $611.
  • West Pharmaceutical made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #763 holding.
  • Capital Advisors Ltd first reported a position in West Pharmaceutical in Q4 2021 and has held it in 17 quarters since.
  • 120 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.